Immune Aging Map Decodes Disease Risks
Scientists have identified a protein signature in blood linked to a higher risk of age-related diseases. The discovery could help predict chronic disease risks and improve treatment decisions.
Researchers have found that a certain ratio of proteins produced by immune cells in the blood is associated with a higher risk of age-related diseases. Lutz Menzel, Ph.D., and Tim Padera, Ph.D., led the study, which combined mouse experiments and human data sets to explore how biological sex and aging shape cancer immunity.
The study found that aging is accompanied by a gradual decline in immune function, reducing the ability to mount effective responses against infections and cancer. This decline presents a challenge in the context of cancer immunotherapy, as treatments rely on the immune system's ability to recognize and respond to tumor antigens.
The researchers investigated how age and biological sex shape anticancer immunity through the lens of T cell immunity, immune surveillance, and the ability to recognize cancer antigens. They tracked changes in lymph nodes, the thymus, and naive CD8 T cells across the life span of female and male mice.
The study also found that having more granzyme K-producing white blood cells is associated with healthy aging, while having more granzyme B-producing cells is linked to chronic disease and even death. The discovery could help identify individuals at risk of age-related diseases and improve treatment decisions.
The researchers used mouse models and human imaging and immune-cell data sets to determine whether similar age- and sex-associated patterns occur in people. The study's findings have implications for immunotherapy responses and could ultimately enable more individualized treatment decisions.
The study's lead author, Lutz Menzel, Ph.D., and senior author, Tim Padera, Ph.D., are from the Mass General Brigham Cancer Institute. The paper is titled 'Lymph node contraction links sex-biased naive CD8 T cell decline to compromised antigen recognition during middle age.'
WashU Medicine researchers also found that a ratio between two immune cell types can reveal whether someone stays healthy or may face a higher risk of future disease. The study's findings highlight the importance of understanding how age and biological sex shape anticancer immunity.
Key facts
- A certain ratio of proteins produced by immune cells in the blood is linked to a higher risk of age-related diseases.
- Aging is accompanied by a gradual decline in immune function, reducing the ability to mount effective responses against infections and cancer.
- The study found that having more granzyme K-producing white blood cells is associated with healthy aging, while having more granzyme B-producing cells is linked to chronic disease and even death.
- The discovery could help identify individuals at risk of age-related diseases and improve treatment decisions.
Three perspectives
Neutral
The study's findings provide new insights into how age and biological sex shape anticancer immunity. The discovery could help identify individuals at risk of age-related diseases and improve treatment decisions. Further research is needed to fully understand the implications of the study's findings.
Positive
The study's findings have the potential to improve treatment decisions and outcomes for individuals with age-related diseases. The discovery of a protein signature in blood linked to a higher risk of age-related diseases could lead to the development of new diagnostic tools and therapies.
Negative
The study's findings highlight the challenges of aging and the decline in immune function. The discovery that having more granzyme B-producing cells is linked to chronic disease and even death shows the need for further research into the underlying mechanisms of age-related diseases.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.